Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9568087rdf:typepubmed:Citationlld:pubmed
pubmed-article:9568087lifeskim:mentionsumls-concept:C1512505lld:lifeskim
pubmed-article:9568087lifeskim:mentionsumls-concept:C0021701lld:lifeskim
pubmed-article:9568087lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9568087lifeskim:mentionsumls-concept:C0205349lld:lifeskim
pubmed-article:9568087lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:9568087lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:9568087pubmed:issue1Alld:pubmed
pubmed-article:9568087pubmed:dateCreated1998-5-13lld:pubmed
pubmed-article:9568087pubmed:abstractTextWe investigated alterations in the expression of integrin on adriamycin-resistant MCF-7 (MCF-7/ADR) cells, which had been selected from MCF-7 human breast cancer cells, in order to examine the mechanisms behind the acquisition of malignancy in breast cancer progression. Expression of the alpha 6 integrin subunit of MCF-7/ADR cells was stronger than that of MCF-7 cells, whereas expression of alpha 2 integrin subunit of MCF-7/ADR cells was weaker than that of MCF-7 cells. MCF-7/ADR showed increased binding activity to laminin, but not to collagen or fibronectin, compared to those of parental MCF-7 cells. Adhesion of MCF-7 cells to collagen and laminin was inhibited by the addition of antibody to alpha 2 and alpha 6 integrin subunit, respectively. On the other hand, adhesion of MCF-7/ADR cells to collagen was not inhibited by the addition of antibody to alpha 2, alpha 3 or alpha 6 integrin subunit. Adhesion of MCF-7/ADR cells to laminin was inhibited by not only the antibody to alpha 6 subunit but also the antibody to the alpha 3 subunit. The transmigratory activity of MCF-7/ADR cells was higher than that of MCF-7 cells. A significant inhibitory effect on the transmigration of MCF-7/ADR cells was observed by the addition of antibody to alpha 6 and beta 1 integrin subunit. MCF-7/ADR cells appeared smaller and flatter than MCF-7 cells, and spread to a greater extent on the culture dish. MCF-7 cells cultured on Matrigel for 24 hours formed clusters. In contrast to this, MCF-7/ADR cells expanded with a tubular-like pattern on Matrigel. The spread of MCF-7/ADR cells was incompletely inhibited by addition of the antibody to alpha 3 integrin subunit, and completely inhibited by addition of the antibody to alpha 6 and beta 1 integrin subunit. These findings suggest that integrins on MCF-7/ADR cells are altered from those on parental MCF-7 cells in not only expression but also function, and that interaction between cancer cells and extracellular matrix protein is involved in augmentation of the invasiveness of MCF-7/ADR cells.lld:pubmed
pubmed-article:9568087pubmed:languageenglld:pubmed
pubmed-article:9568087pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9568087pubmed:citationSubsetIMlld:pubmed
pubmed-article:9568087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9568087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9568087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9568087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9568087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9568087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9568087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9568087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9568087pubmed:statusMEDLINElld:pubmed
pubmed-article:9568087pubmed:issn0250-7005lld:pubmed
pubmed-article:9568087pubmed:authorpubmed-author:NaritaTTlld:pubmed
pubmed-article:9568087pubmed:authorpubmed-author:MatsuuraNNlld:pubmed
pubmed-article:9568087pubmed:authorpubmed-author:SatoMMlld:pubmed
pubmed-article:9568087pubmed:authorpubmed-author:KimuraNNlld:pubmed
pubmed-article:9568087pubmed:authorpubmed-author:KannagiRRlld:pubmed
pubmed-article:9568087pubmed:issnTypePrintlld:pubmed
pubmed-article:9568087pubmed:volume18lld:pubmed
pubmed-article:9568087pubmed:ownerNLMlld:pubmed
pubmed-article:9568087pubmed:authorsCompleteYlld:pubmed
pubmed-article:9568087pubmed:pagination257-62lld:pubmed
pubmed-article:9568087pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:meshHeadingpubmed-meshheading:9568087-...lld:pubmed
pubmed-article:9568087pubmed:articleTitleAltered expression of integrins in adriamycin-resistant human breast cancer cells.lld:pubmed
pubmed-article:9568087pubmed:affiliationLaboratory of Experimental Pathology, Aichi Cancer Center Research Institute, Nagoya, Japan.lld:pubmed
pubmed-article:9568087pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9568087lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9568087lld:pubmed